Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07752420

Effects of Structural Integration on Chest Wall Expansion Among COPD Patients

The present study aims to investigate the effects of the 10-Series of Structural Integration on chest wall expansion in patients with stable COPD using a randomized controlled trial design. Participants receiving Structural Integration in addition to conventional pulmonary rehabilitation will be compared with those receiving conventional pulmonary rehabilitation alone. Chest wall expansion will serve as the primary outcome, while pulmonary function, dyspnea, functional exercise capacity, and quality of life may be evaluated as secondary outcomes.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

COPD (With - Without Rehabilitation) Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

50 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinically diagnosed stable COPD according to GOLD criteria
  • GOLD stage II or III
  • No acute exacerbation within the previous four weeks
  • Able to ambulate independently
  • Medically cleared to participate in pulmonary rehabilitation
  • Willing to provide written informed consent

Exclusion criteria

  • Severe cardiovascular disease contraindicating exercise
  • Recent thoracic or abdominal surgery (<6 months)
  • Rib fractures or severe chest wall deformity
  • Neurological disorders affecting mobility
  • Active malignancy
  • Severe osteoporosis with high fracture risk
  • Previous Structural Integration treatment within the last year

Treatment and study plan

Structural Integration with Conventional Pulmonary Rehabilitation

Other
  • Conventional pulmonary rehabilitation.
  • The complete 10-Series of Structural Integration, delivered by a certified Structural Integration practitioner/physiotherapist.

Pulmonary Rehabilitation only

Other

Participants receive only the conventional pulmonary rehabilitation program.

Primary outcomes

  1. Chest Wall Expansion

    Time frame: Before the start and end of 10 weeks

    Chest wall expansion will be measured using a flexible measuring tape at:

    • Axillary level
    • Xiphoid level
    • Lower thoracic level (10th rib) Measurements will be taken during maximal inspiration and maximal expiration. The difference (in centimeters) will be recorded. Three readings will be obtained at each level, and the average value will be used for analysis.

Study contacts

Contact information is provided by the study sponsor or research team.

Mohtishim Ahmed, MSPT, DPT

CONTACT

[email protected]

+923224057371

Sponsors and collaborators

Lead sponsor

Green International University

Other

Registry information

Official study title

Effects of "The 10-Series of Structural Integration" on Chest Wall Expansion Among COPD Patients

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 7, 2026
Registry last updated
Aug 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.